Sartorius vz. Aktie 346908 / DE0007165631
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
16.02.2026 09:08:53
|
EQS-News: Sartorius releases Annual Report for 2025
|
EQS-News: SARTORIUS AG
/ Key word(s): Annual Report
Göttingen, Germany | February 16, 2026
Sartorius releases Annual Report for 2025 The life science group Sartorius today released its Annual Report for 2025. The document is available at the following link: https://www.sartorius.com/ar2025 Financial calendar March 26,2026 | Annual General Meeting April 23,2026 | Publication of the first quarter results for January to March 2026 July 23,2026 | Publication of half-year results for January to June 2026 October 22,2026 | Publication of nine-month results for January to September 2026 A profile of Sartorius Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2025, the company generated sales revenue of around 3.5 billion euros. More than 14,000 employees serve customers around the globe. Visit our newsroom and follow us on LinkedIn. Contact Verena Sattel External Communications +49 551 308 9261 verena.sattel@sartorius.com Additional features: File: Sartorius releases Annual Report for 2025 | Media Release
16.02.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | SARTORIUS AG |
| Otto-Brenner-Strasse 20 | |
| 37079 Göttingen | |
| Germany | |
| Phone: | +49.(0)551-308.0 |
| Fax: | +49.(0)551-308.3289 |
| E-mail: | info@sartorius.com |
| Internet: | www.sartorius.com |
| ISIN: | DE0007165631, DE0007165607 |
| WKN: | 716563, 716560 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2275076 |
| End of News | EQS News Service |
|
|
2275076 16.02.2026 CET/CEST
Nachrichten zu Sartorius AG Vz.
|
27.03.26 |
Freitagshandel in Frankfurt: TecDAX legt letztendlich den Rückwärtsgang ein (finanzen.ch) | |
|
26.03.26 |
TecDAX aktuell: TecDAX legt schlussendlich den Rückwärtsgang ein (finanzen.ch) | |
|
26.03.26 |
Handel in Frankfurt: MDAX zeigt sich schlussendlich leichter (finanzen.ch) | |
|
26.03.26 |
EQS-News: Sartorius AG Supervisory Board extends appointment of board member René Fáber (EQS Group) | |
|
26.03.26 |
EQS-News: Sartorius-Aufsichtsrat verlängert Bestellung von Vorstandsmitglied René Fáber (EQS Group) | |
|
26.03.26 |
Börse Frankfurt in Rot: TecDAX legt den Rückwärtsgang ein (finanzen.ch) | |
|
26.03.26 |
EQS-News: Sartorius AG - Resolutions of the Annual General Meeting (EQS Group) | |
|
26.03.26 |
EQS-News: Sartorius AG – Beschlüsse der Hauptversammlung (EQS Group) |
Analysen zu Sartorius AG Vz.
| 25.03.26 | Sartorius vz. Buy | Deutsche Bank AG | |
| 25.03.26 | Sartorius vz. Outperform | Bernstein Research | |
| 23.03.26 | Sartorius vz. Neutral | UBS AG | |
| 20.03.26 | Sartorius vz. Overweight | Barclays Capital | |
| 19.03.26 | Sartorius vz. Buy | Deutsche Bank AG |
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Talanax
✅ Applied Materials
✅ Parker Hannifin
https://bxplus.ch/bx-musterportfolio/
3 Knaller-Aktien im BX Musterportfolio: Talanx, Applied Materials, Parker Hannifin mit François Bloch
Anzeige
Inside Trading & Investment
Anzeige
Mini-Futures auf SMI
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB),
sowie Informationen zu Chancen und Risiken,
finden Sie unter: https://keyinvest-ch.ubs.com
Anzeige
Inside Fonds
Aktien in diesem Artikel
| Sartorius AG Vz. | 185.85 | -2.90% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI und DAX gehen leichter ins Wochenende -- Wall Street beendet Handel im Minus -- Asiens Börsen letztlich mehrheitlich in GrünDie heimische Aktienmarkt sowie der deutsche Leitindex verabschiedeten sich am Freitag mit Abschlägen. Auch die US-Börsen verbuchten Verluste. Die Börsen in Fernost bewegten sich am Freitag vorwiegend auf höherem Niveau.